Diferido
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
1.760 INR | -0,09 % | +0,87 % | -8,38 % |
Resumen de negocios
Número de empleados: 4 585
Ventas por actividad
INR en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Generic Injectibles
100,0
%
| 44 007 | 100,0 % | 36 246 | 100,0 % | -17,64 % |
Ventas por región
INR en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
57,7
%
| 23 327 | 53,0 % | 20 910 | 57,7 % | -10,36 % |
Rest of World
19,0
%
| 8 481 | 19,3 % | 6 893 | 19,0 % | -18,73 % |
India
15,3
%
| 8 801 | 20,0 % | 5 548 | 15,3 % | -36,96 % |
Europe
5,2
%
| 2 398 | 5,4 % | 1 871 | 5,2 % | -21,97 % |
Canada
2,2
%
| 829 | 1,9 % | 795 | 2,2 % | -4,14 % |
Australia
0,6
%
| 171 | 0,4 % | 218 | 0,6 % | +27,72 % |
New Zealand
0,0
%
| - | - | 11 | 0,0 % | - |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Srinivas Sadu
CEO | Chief Executive Officer | 55 | 01/01/00 |
Director of Finance/CFO | - | 30/09/19 | |
C. S. Venkatesan
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/98 |
Compliance Officer | - | 01/12/10 | |
Chief Tech/Sci/R&D Officer | - | 01/01/02 | |
Chief Operating Officer | - | 01/01/16 | |
Manish Bharadwaj
HRO | Human Resources Officer | - | - |
Rong Wu
AUD | Comptroller/Controller/Auditor | - | - |
Shilpi Sahay
PRN | Corporate Officer/Principal | - | 01/01/14 |
Ashish Adhikari
PRN | Corporate Officer/Principal | - | 12/08/19 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Fang Yao
BRD | Director/Board Member | 54 | 10/03/22 |
Srinivas Sadu
CEO | Chief Executive Officer | 55 | 01/01/00 |
Yiu Kwan Lau
CHM | Chairman | 69 | 10/06/19 |
Qi Yu Chen
BRD | Director/Board Member | 52 | 03/10/17 |
Director/Board Member | 69 | 07/02/18 | |
Naina Lal Kidwai
BRD | Director/Board Member | 67 | 17/05/21 |
Director/Board Member | 57 | 20/11/18 | |
Director/Board Member | - | 30/09/20 | |
Jia Ai Zhang
BRD | Director/Board Member | - | 17/05/21 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 164 710 523 | 63 214 104 ( 38,38 %) | 0 | 38,38 % |
Información de la empresa
Gland Pharma Ltd.
TSIIC Phase: IV Plot No. 11 & 84
502307, Sangareddy
+91 84 5569 9999
http://www.glandpharma.comEmpresas del grupo
Nombre | Categoría y sector |
---|---|
Gland Pharma International Pte Ltd.
Gland Pharma International Pte Ltd. Pharmaceuticals: MajorHealth Technology Gland Pharma International Pte Ltd. is a Singaporean company that manufactures liquid parenteral products. The private company is based in Singapore, Singapore and was founded in 2021. |
Pharmaceuticals: Major
|
Ventas por región
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
+27,97 % | 672 mil M | |
+23,58 % | 550 mil M | |
-7,02 % | 351 mil M | |
+14,85 % | 317 mil M | |
+6,25 % | 292 mil M | |
+2,96 % | 211 mil M | |
-0,41 % | 203 mil M | |
-10,02 % | 194 mil M | |
-11,81 % | 144 mil M |
- Bolsa de valores
- Acciones
- Acción GLAND
- Acción GLAND
- Empresa Gland Pharma Limited